Private Advisor Group, LLC Immuno Gen, Inc. Transaction History

Private Advisor Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$3.45 - $4.89 $921 - $1,305	-267 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$3.32 - $5.34 $886 - $1,425	267 New	267 $1,000
Q1 2019 May 13, 2019	SELL	$2.41 - $5.91 $27,956 - $68,556	-11,600 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$3.94 - $9.7 $45,704 - $112,519	11,600 New	11,600 $56,000
Q3 2018 Nov 01, 2018	SELL	$8.6 - $11.26 $114,414 - $149,803	-13,304 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$9.52 - $12.15 $126,654 - $161,643	13,304 New	13,304 $131,000
Q4 2017 Feb 07, 2018	SELL	$5.07 - $7.92 $58,604 - $91,547	-11,559 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$5.4 - $8.47 $62,418 - $97,904	11,559	11,559 $77,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.